Specifically, in terms of neurodevelopmental functions, patients with mutations in the MAP2K2 gene show a lower incidence of intellectual disability (ID) compared to those with mutations in other genes, such as BRAF and MAP2K1, with an incidence rate of only 25%. The gene discussed is MAP2K2; the disease is Intellectual disability.